COVID-19: Coronavirus vaccine could be at hospitals within 10 days – reports – Sky News

Last Updated on November 28, 2020 by

A COVID-19 vaccine could be available at hospitals in England in as few as 10 days, it has been reported.

The first deliveries of the Pfizer/BioNTech jab could take place as soon as 7 December, according to The Guardian.

The inoculation was found to have an efficacy of 95% according to early reports.

An illustration picture shows vials with Covid-19 Vaccine stickers attached and syringes with the logo of US pharmaceutical company Pfizer and German partner BioNTech, on November 17, 2020. (Photo by JUSTIN TALLIS / AFP) (Photo by JUSTIN TALLIS/AFP via Getty Images)

The Pfizer/BioNTech vaccine is up to 95% effective

The vaccinations are expected to be used for staff at the hospitals.

But whether or not this happens depends on if the treatment is given approval by the Medicines and Healthcare Products Regulatory Agency (MHRA).

It is understood that NHS England has not given confirmation for the jab to be dispersed – and that several steps still need to be completed.

However, a 10-day timeframe to get the jab out once approval is given by the MHRA is understood to be a reasonable expectation.

Health Secretary Matt Hancock asked the MHRA to assess the Pfizer/BioNTech vaccine on 20 November for use in the UK.

It was also reported that the vaccine will be given to NHS staff first because of its short shelf life and also the difficulties associated with storing, including needing to be stored at a temperature of around -70C.

:: Subscribe to the Daily podcast on Apple Podcasts, Google Podcasts, Spotify, Spreaker

Guidance from the Joint Committee on Vaccination and Immunisation (JCVI) said older care home residents were higher priority than health and social care workers – who were on equal footing with the over-80s.

However, the guidance stipulated the final decision on how health and social care workers were treated would depend on the characteristics of the jab.

The UK has 40 million orders for the Pfizer/BioNTech vaccine, compared to 100 million for the Oxford/AstraZeneca alternative.

Leave a Comment